Literature DB >> 7615376

Cytomegalovirus-associated hepatitis and duodenal ulcer in kidney allograft recipients.

T Yagisawa1, N Kaneko, Y Iijima, K Izumiya, H Yaguchi, T Nakada.   

Abstract

We report here on two patients with kidney allografts who had hepatitis and duodenal ulcer caused by cytomegalovirus. In one case, hepatosplenomegaly and jaundice appeared after high fever lasting for ten days. Laboratory examinations showed liver dysfunction and lymphocytosis with atypical forms. Virological studies revealed cytomegalovirus infection and we successfully treated the patient with human interferon-beta. In the other case, duodenal bleeding followed by interstitial pneumonia occurred at the 54th day after transplantation. Bleeding from the small duodenal ulcer did not stop in spite of conservative and endoscopic therapies, and gastrectomy was performed. Histologically many epithelial cells with intranuclear inclusions were found around the ulcer. Virological studies showed elevation of antibody titres to cytomegalovirus which was isolated from the urine and oropharyngeal secrete. After gastrectomy and treatment with ganciclovir, the general condition improved and graft function was maintained. Our experience with these cases suggests that aggressive diagnostic investigations for cytomegalovirus infection are essential in patients with organ allografts who present liver and gastrointestinal lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615376     DOI: 10.1007/BF02575214

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  13 in total

Review 1.  Liver disease in renal transplant recipients.

Authors:  J Sopko; S Anuras
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

2.  Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients.

Authors:  R H Rubin; A B Cosimi; N E Tolkoff-Rubin; P S Russell; M S Hirsch
Journal:  Transplantation       Date:  1977-12       Impact factor: 4.939

3.  Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.

Authors:  G M Schmidt; A Kovacs; J A Zaia; D A Horak; K G Blume; A P Nademanee; M R O'Donnell; D S Snyder; S J Forman
Journal:  Transplantation       Date:  1988-12       Impact factor: 4.939

4.  Effect of human interferon-beta on life-threatening viral pneumonitis in kidney transplant recipients.

Authors:  K Takahashi; S Teraoka; T Yagisawa; S Fuchinoue; H Honda; H Toma; T Agishi; K Ota
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

5.  Relationship between cytomegalovirus and hepatic function abnormalities in the period after renal transplant.

Authors:  J P Luby; W Burnett; A R Hull; A J Ware; J W Shorey; P C Peters
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

6.  Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

Authors:  J D Meyers; J Leszczynski; J A Zaia; N Flournoy; B Newton; D R Snydman; G G Wright; M J Levin; E D Thomas
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

7.  Cytomegalovirus infection of the upper gastrointestinal tract before and after liver transplantation.

Authors:  J A Alexander; R E Cuellar; R J Fadden; J J Genovese; J S Gavaler; D H Van Thiel
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

8.  Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique.

Authors:  H Einsele; M Steidle; A Vallbracht; J G Saal; G Ehninger; C A Müller
Journal:  Blood       Date:  1991-03-01       Impact factor: 22.113

9.  Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients.

Authors:  M A Harbison; P C De Girolami; R L Jenkins; S M Hammer
Journal:  Transplantation       Date:  1988-07       Impact factor: 4.939

10.  The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.

Authors:  R M Lewis; P C Johnson; D Golden; C T Van Buren; R H Kerman; B D Kahan
Journal:  Transplantation       Date:  1988-02       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.